Biogen (BIIB) Leases (2016 - 2025)
Historic Leases for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $265.4 million.
- Biogen's Leases fell 2553.31% to $265.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $265.4 million, marking a year-over-year decrease of 2553.31%. This contributed to the annual value of $265.4 million for FY2025, which is 2553.31% down from last year.
- According to the latest figures from Q4 2025, Biogen's Leases is $265.4 million, which was down 2553.31% from $330.5 million recorded in Q3 2025.
- Over the past 5 years, Biogen's Leases peaked at $460.9 million during Q3 2023, and registered a low of $265.4 million during Q4 2025.
- Its 5-year average for Leases is $378.4 million, with a median of $384.8 million in 2021.
- In the last 5 years, Biogen's Leases skyrocketed by 1413.89% in 2023 and then crashed by 2553.31% in 2025.
- Over the past 5 years, Biogen's Leases (Quarter) stood at $375.4 million in 2021, then grew by 7.59% to $403.9 million in 2022, then grew by 3.99% to $420.0 million in 2023, then dropped by 15.14% to $356.4 million in 2024, then decreased by 25.53% to $265.4 million in 2025.
- Its last three reported values are $265.4 million in Q4 2025, $330.5 million for Q3 2025, and $334.5 million during Q2 2025.